Printed from Voxsanity (voxsanity.com.au) — NCT07402525 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Head And Neck Cancer
Head and Neck Cancer Trial, Recruiting
NCT07402525
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 70 years old (any gender)
- People who have not previously received radiation therapy, chemotherapy, or targeted therapy for their cancer
- People whose surgeon was able to fully remove the tumor, with no remaining cancer found when the removed tissue was examined in the laboratory
- People whose cancer is located on the front two-thirds of the tongue (the part of the tongue that moves)
- People whose laboratory results after surgery confirmed the cancer type as squamous cell carcinoma of the tongue
- People whose cancer is classified as an early stage (T1-2N0M0) according to a standard staging system called the AJCC 8th edition
- People whose cancer has at least one of these features found in the laboratory: cancer cells found in blood or lymph vessels, cancer cells growing into nearby nerves, or cancer cells that appear moderately or poorly formed under a microscope
- People whose general health is rated as good to fairly well-functioning on a standard scale used in cancer care (ECOG score of 0–2)
- People who have not been enrolled in another clinical trial in the 4 weeks before screening (confirm with trial site for details on exceptions)
Who may not be able to join:
- People whose cancer has spread into nearby areas such as the throat, floor of the mouth, cheeks, neck, or other organs
- People who have previously received chemotherapy or other anti-cancer drug treatments
- People who have previously received radiation therapy to the head or neck area
- People who have an active autoimmune disease that has required ongoing treatment
- People who are pregnant or currently breastfeeding
- People who have a serious infection that is difficult to control
- People with a history of substance misuse, long-term heavy alcohol use, or HIV/AIDS
- People who have another active cancer diagnosis (exceptions may apply for cancers that have been successfully treated with no signs of return for more than 2 years — confirm with trial site)
- People whom the research team determines have other circumstances that would make participation in the trial unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 January 2026
Est. completion
30 January 2031
Where this trial is recruiting
🇨🇳 China
Primary endpoints
3-year DFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.